ClinicalTrials.govpublic full text
Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
initial radiological diagnosis eligible for tumor resection, initial radiological diagnosis compatible with newly diagnosed glioblastoma (idh wild-type), eligible for the standard of care including concurrent temoradiation and adjuvant temozolomide, primary brain cancer, glioblastoma, first line, stupp protocol, ultrasounds, medical device, sc9, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804380
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.